News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Emad Shash: We have three abstracts at the upcoming ESMO 2024 Congress
Emad Shash/LinkedIn
Jul 14, 2024, 04:10

Emad Shash: We have three abstracts at the upcoming ESMO 2024 Congress

Emad Shash, General Manager of the Breast Cancer Comprehensive Center of the National Cancer Institute at Cairo University, shared on LinkedIn:

“I am thrilled to announce that three abstracts from the Breast Cancer Comprehensive Center of the National Cancer Institute, Cairo University, have been accepted for poster presentation at the upcoming ESMO 2024 Congress in Barcelona, Spain!

  1. Evaluating Adherence to Oral Anticancer Medications in Metastatic and Non-Metastatic Breast Cancer Patients.
  2. Evaluation of Acceptance and Perceived Barriers to Mobile Health Applications among Breast Cancer Patients and Caregivers at the National Cancer Institute, Cairo University.
  3. Impact of Adjuvant Hormonal Therapy on Sexual and Global Quality of Life in Young Egyptian Women with Breast Cancer.

I am incredibly proud of my team for their dedication and hard work in enhancing breast cancer patient outcomes. Together, we are making a difference!”

Emad Shash

Source: Emad Shash/LinkedIn

.

Adjuvant Hormonal Therapy Barcelona Breast Cancer Breast Cancer Comprehensive Center breast cancer patients Cairo University cancer Emad Shash ESMO 2024 Congress Medical Director National Cancer Institute OncoDaily Oncology Sexual and Global Quality Spain Young Egyptian Women
Special Coverage
Insight
Jan 20, 2025, 12:28
Myeloma Paper of the Day, January 20th, suggested by Robert Orlowski
Blog
Jan 20, 2025, 12:26
The first seminar of 2025 NCI Rising Scholars: Cancer Research Seminar Series
Blog
Jan 20, 2025, 12:16
Rita A. Sakr: Honored to present dear breast cancer survivors at SABCS24
Blog
Jan 20, 2025, 12:11
Catharine Young: Real progress doesn’t happen in isolation
Blog
Jan 20, 2025, 11:28
Fernanda Rivera's Journey as the first Mexican RadOnc Resident to receive the ASCO IDEA Award
Blog
Jan 20, 2025, 04:32
Bevacizumab and carboplatin-pemetrexed chemotherapy with/out atezolizumab for advanced pleural mesothelioma
Blog
Jan 20, 2025, 04:29
Katsuaki Maehara: Lung EGFR mutations catalog
Opinion
Jan 20, 2025, 04:25
Elisabetta Bonzano: The identification and validation of patient-specific vulnerabilities
Blog
Jan 20, 2025, 04:21
Robin Zon: Behind every diagnosis, test, approval/ disapproval and outcome is a patient and their family
Insight
Jan 20, 2025, 04:14
Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra
Insight
Jan 20, 2025, 04:00
FDA approved datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer
Career
Jan 20, 2025, 03:10
Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research